Search Results

Analysis of the efficacy and safety of denosumab in the treatment of patients with osteoporotic vertebral compression fractures after PVP.

• Authors : Jiang, Yixuan¹ (AUTHOR); He, Bowen² (AUTHOR); Shang, Qi^3,4 (AUTHOR)

• Source: Scientific Reports. 11/19/2025, Vol. 15 Issue 1, p1-12. 12p.

Record details

Adherence to denosumab therapy and fracture risk associated with drug withdrawal: a retrospective study.

• Authors : Özdemir, Hande¹ ; Kakilli, Nur¹; Tuna, Filiz¹

• Source: Croatian Medical Journal. Oct2025, Vol. 66 Issue 5, p334-344. 11p.

Record details

Cost-consequence analysis of continuous denosumab therapy for osteoporosis treatment in South Korea.

• Authors : Cha, Seungju¹ (AUTHOR); Sohn, Minjeong² (AUTHOR); Yang, Hyowon² (AUTHOR)

• Source: BMC Musculoskeletal Disorders. 1/20/2024, Vol. 25 Issue 1, p1-11. 11p.

Record details

Comparative Analysis of Romosozumab Versus Vertebroplasty With Denosumab: Efficacy, Safety, and Secondary Bone Mineral Density Outcomes.

• Authors : Mun, Hyun Woong¹ (AUTHOR); Lee, Jong Joo¹ (AUTHOR); Shin, Hyun Chul¹ (AUTHOR)

• Source: Neurospine. Mar2025, Vol. 22 Issue 1, p69-77. 9p.

Record details

Similarities and Differences in the Management of Patients with Osteoporotic Vertebral Fractures and Those with Rebound-Associated Vertebral Fractures Following Discontinuation of Denosumab.

• Authors : Anastasilakis, Athanasios D.¹ (AUTHOR) ; Makras, Polyzois^2,3 (AUTHOR) ; Paccou, Julien⁴ (AUTHOR)

• Source: Journal of Clinical Medicine. Sep2023, Vol. 12 Issue 18, p5874. 11p.

Record details

A scoping review on the safety, efficacy, and effectiveness profile of different antiresorptives for the management of patients with secondary osteoporosis due to transplants.

• Authors : Tandayamo Sisalima, Luis Fernando¹; Muñoz, Natalia Flórez²; Meza Toscano, Aldair Aristides³

• Source: Journal of Osteoporosis & Mineral Metabolism / Revista de Osteoporosis y Metabolismo Mineral (English edition). jul-sep2025, Vol. 17 Issue 3, p107-116. 10p.

Record details

Denosumab use in osteogenesis imperfecta: an update on therapeutic approaches.

• Authors : Majdoub, Fatma^1,2,3 ; Ferjani, Hanene Lassoued^1,2,3; Nessib, Dorra Ben^1,2,3

• Source: Annals of Pediatric Endocrinology & Metabolism. Jun2023, Vol. 28 Issue 2, p98-106. 9p.

Record details

A Real‐world Study of Denosumab For Reducing Refracture Risk after Percutaneous Vertebral Augmentation.

• Authors : Zou, Jun¹ (AUTHOR) ; Zhang, Yijian¹ (AUTHOR); Niu, Junjie¹ (AUTHOR)

• Source: Orthopaedic Surgery. Aug2024, Vol. 16 Issue 8, p1849-1860. 12p.

Record details

Multiple Spontaneous Vertebral Fractures in a Younger Post-menopausal Woman Upon Stopping Denosumab Therapy.

• Authors : Hu, Xun Yang¹ (AUTHOR); Leslie, William D² (AUTHOR); Kline, Gregory¹ (AUTHOR)

• Source: JCEM Case Reports. May2023, Vol. 1 Issue 3, p1-4. 4p.

Record details

Osteonecrosis in the context of denosumab -- Perspective of the bone metabolism specialist and the maxillofacial specialist.

• Source: Journal of Osteoporosis & Mineral Metabolism / Revista de Osteoporosis y Metabolismo Mineral (English edition). ene-mar2024, Vol. 16 Issue 1, p16-23. 14p.

Record details